Athenex Provides Second Quarter 2021 Corporate and Financial Update

NEXT STORY
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2021
PREV STORY
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma to Present at the 16th Annual PEGS Boston Essential Protein Engineering & Cell Therapy Summit

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal

author_avatar
NASDAQ Market News

Sentia Medical Sciences Inc. Awarded Approximately $1.8 million Phase II Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)

author_avatar
NASDAQ Market News